Startups
Draupnir Bio is developing a new type of cholesterol-lowering medicine which prevents blood clots in the heart.
Summary
31
Industry
Total funding Amount
$33M
Fundraising History
-
Oct 01 '19 Unknown$33M
Investors
-
High-Tech GründerfondsUnknown
-
Inkef CapitalUnknown